ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 130 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $32,749 | -49.9% | 9,894 | -38.8% | 0.01% | -37.5% |
| Q1 2024 | $65,363 | +122.0% | 16,179 | +67.6% | 0.01% | +33.3% |
| Q4 2023 | $29,442 | +358.8% | 9,653 | +351.3% | 0.01% | +200.0% |
| Q3 2023 | $6,417 | +57.0% | 2,139 | +95.7% | 0.00% | +100.0% |
| Q2 2023 | $4,088 | +8.1% | 1,093 | -3.2% | 0.00% | 0.0% |
| Q1 2023 | $3,782 | -7.1% | 1,129 | +33.5% | 0.00% | -50.0% |
| Q4 2022 | $4,069 | +1.7% | 846 | +8.5% | 0.00% | 0.0% |
| Q3 2022 | $4,000 | – | 780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $14,143,000 | 1.69% |
| CM Management, LLC | 250,000 | $1,423,000 | 1.59% |
| Ally Bridge Group (NY) LLC | 360,000 | $2,048,000 | 1.35% |
| EcoR1 Capital, LLC | 6,184,861 | $35,192,000 | 1.04% |
| Cormorant Asset Management, LP | 1,547,181 | $8,803,000 | 0.62% |
| K2 PRINCIPAL FUND, L.P. | 605,419 | $3,445,000 | 0.40% |
| FEDERATED HERMES, INC. | 3,626,818 | $20,637,000 | 0.06% |
| PDT Partners, LLC | 68,754 | $391,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 355,612 | $2,023,000 | 0.05% |
| Virtus ETF Advisers LLC | 15,660 | $89,000 | 0.04% |